美国快速通道与突破性疗法模式的比较研究与借鉴(4)
参考文献
[1] 杨莉, 连桂玉, 邢花, 等. FDA在新药注册审批中的研发激励机制研究[J]. 中国新药杂志, 2012, 21(9): 964-968.
[2] Guidance for Industry Expedited Programs for Serious Conditions – Drugs and Biologics [EB/OL]. (2016-12-20). http://www.fda.gov/downloads/Drugs/Guidance Compliance Regulatory Information/Guidances/UCM358301. Pdf.
[3] Fast Track Drug Development Programs – Designation ......
您现在查看是摘要页,全文长 2566 字符。
[1] 杨莉, 连桂玉, 邢花, 等. FDA在新药注册审批中的研发激励机制研究[J]. 中国新药杂志, 2012, 21(9): 964-968.
[2] Guidance for Industry Expedited Programs for Serious Conditions – Drugs and Biologics [EB/OL]. (2016-12-20). http://www.fda.gov/downloads/Drugs/Guidance Compliance Regulatory Information/Guidances/UCM358301. Pdf.
[3] Fast Track Drug Development Programs – Designation ......
您现在查看是摘要页,全文长 2566 字符。